Wells Fargo raised the firm’s price target on Inspire Medical (INSP) to $198 from $187 and keeps an Equal Weight rating on the shares. The firm notes Inspire reported Q3 sales/EPS ahead of Street expectations and raised 2024 sales/EPS guidance. Q4 sales outlook is slightly softer due to hurricane/IV shortage headwinds, Wells adds.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INSP: